Christoph Hagemeyer

Monash Biomedical Imaging Node Director

Christoph Hagemeyer is the Director of Monash Biomedical Imaging, the Head of the Nanobiotechnology Laboratory in the Department of Diabetes in the School of Translational Medicine and the Monash University Node Director of the Victorian Biomedical Imaging Capability.

Prof Hagemeyer studied Chemistry in Germany and obtained a PhD in Biochemistry from the University of Freiburg (Germany) for contributions to the field of Cytochrome P450 metabolism in the brain. As a postdoctoral fellow, he worked in the field of Magnetic Resonance Imaging (MRI) at the “Centre national de la recherche scientifique” in Bordeaux (France) before migrating to Australia in 2005. He has expertise in the use of small recombinant single-chain antibodies for molecular imaging and drug delivery. He has work extensively in cardiovascular research developing anti-thrombotic fusion proteins and novel imaging probes for MRI, Ultrasound and Positron Emission Tomography.

He has published widely in leading journals (Circ Res, Adv Mater, Angew Chem..) on vascular biology, molecular imaging, recombinant antibodies, and nanotechnology. Prof Hagemeyer has attracted high-quality postgraduate students and postdoctoral fellows. He has been supported throughout his career by national and international fellowships and grants.